$16.01
0.311.94%
At close: -
$16.01
0.000.00%
After Hours: May 2, 4:00 PM EDT
Comments
Loading...
Crescent Capital BDC Analyst Ratings and Price Targets | NASDAQ:CCAP | Benzinga
Crescent Capital BDC Inc has a consensus price target of $18.58 based on the ratings of 6 analysts. The high is $20 issued by Ladenburg Thalmann on September 30, 2024. The low is $16 issued by Wells Fargo on April 28, 2025. The 3 most-recent analyst ratings were released by Wells Fargo, Keefe, Bruyette & Woods, and Wells Fargo on April 28, 2025, April 8, 2025, and February 21, 2025, respectively. With an average price target of $17.5 between Wells Fargo, Keefe, Bruyette & Woods, and Wells Fargo, there's an implied 9.31% upside for Crescent Capital BDC Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Wells Fargo
Keefe, Bruyette & Woods
Ladenburg Thalmann
B of A Securities
Raymond James
1calculated from analyst ratings
Analyst Ratings for Crescent Capital BDC
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/28/2025 | Buy Now | -0.06% | Wells Fargo | Finian O'Shea64% | $18 → $16 | Maintains | Equal-Weight | Get Alert |
| 04/08/2025 | Buy Now | 15.55% | Keefe, Bruyette & Woods | Ryan Lynch52% | $20 → $18.5 | Maintains | Outperform | Get Alert |
| 02/21/2025 | Buy Now | 12.43% | Wells Fargo | Finian O'Shea64% | $19 → $18 | Maintains | Equal-Weight | Get Alert |
| 01/29/2025 | Buy Now | 18.68% | Wells Fargo | Finian O'Shea64% | $18 → $19 | Maintains | Equal-Weight | Get Alert |
| 11/25/2024 | Buy Now | 24.92% | Keefe, Bruyette & Woods | Ryan Lynch52% | $19 → $20 | Maintains | Outperform | Get Alert |
| 09/30/2024 | Buy Now | 24.92% | Ladenburg Thalmann | Mickey Schleien68% | → $20 | Initiates | → Buy | Get Alert |
| 08/15/2024 | Buy Now | 18.68% | B of A Securities | Derek Hewett50% | $20 → $19 | Maintains | Buy | Get Alert |
| 08/14/2024 | Buy Now | 12.43% | Wells Fargo | Finian O'Shea64% | $19 → $18 | Maintains | Equal-Weight | Get Alert |
| 07/26/2024 | Buy Now | 18.68% | Wells Fargo | Finian O'Shea64% | $18 → $19 | Maintains | Equal-Weight | Get Alert |
| 05/23/2024 | Buy Now | 18.68% | Keefe, Bruyette & Woods | Ryan Lynch52% | $18.5 → $19 | Maintains | Outperform | Get Alert |
| 05/13/2024 | Buy Now | 12.43% | Wells Fargo | Finian O'Shea64% | $16.5 → $18 | Maintains | Equal-Weight | Get Alert |
| 05/10/2024 | Buy Now | 18.68% | Raymond James | Robert Dodd65% | $18 → $19 | Maintains | Outperform | Get Alert |
| 02/23/2024 | Buy Now | 18.68% | Oppenheimer | Mitchel Penn46% | $18 → $19 | Maintains | Outperform | Get Alert |
| 01/29/2024 | Buy Now | 3.06% | Wells Fargo | Finian O'Shea64% | $16 → $16.5 | Maintains | Equal-Weight | Get Alert |
| 11/13/2023 | Buy Now | -0.06% | Wells Fargo | Finian O'Shea64% | $16.5 → $16 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 05/16/2023 | Buy Now | 12.43% | Oppenheimer | Mitchel Penn46% | → $18 | Reiterates | Outperform → Outperform | Get Alert |
| 04/11/2023 | Buy Now | 12.43% | Keefe, Bruyette & Woods | Ryan Lynch52% | → $18 | Initiates | → Outperform | Get Alert |
| 02/24/2023 | Buy Now | 12.43% | Oppenheimer | Mitchel Penn46% | $19 → $18 | Maintains | Outperform | Get Alert |
| 10/05/2022 | Buy Now | 12.43% | Raymond James | Robert Dodd65% | $20.5 → $18 | Maintains | Outperform | Get Alert |
| 08/12/2022 | Buy Now | 18.68% | Oppenheimer | Mitchel Penn46% | $20 → $19 | Upgrade | Perform → Outperform | Get Alert |
| 08/12/2022 | Buy Now | 28.04% | Raymond James | Robert Dodd65% | $21 → $20.5 | Maintains | Outperform | Get Alert |
| 05/11/2022 | Buy Now | 12.43% | Wells Fargo | Finian O'Shea64% | $18.5 → $18 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Crescent Capital BDC (CCAP) stock?
The latest price target for Crescent Capital BDC (NASDAQ:CCAP) was reported by Wells Fargo on April 28, 2025. The analyst firm set a price target for $16.00 expecting CCAP to fall to within 12 months (a possible -0.06% downside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Crescent Capital BDC (CCAP)?
The latest analyst rating for Crescent Capital BDC (NASDAQ:CCAP) was provided by Wells Fargo, and Crescent Capital BDC maintained their equal-weight rating.
When was the last upgrade for Crescent Capital BDC (CCAP)?
The last upgrade for Crescent Capital BDC Inc happened on August 12, 2022 when Oppenheimer raised their price target to $19. Oppenheimer previously had a perform for Crescent Capital BDC Inc.
When was the last downgrade for Crescent Capital BDC (CCAP)?
The last downgrade for Crescent Capital BDC Inc happened on November 13, 2023 when Wells Fargo changed their price target from $16.5 to $16 for Crescent Capital BDC Inc.
When is the next analyst rating going to be posted or updated for Crescent Capital BDC (CCAP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Crescent Capital BDC, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Crescent Capital BDC was filed on April 28, 2025 so you should expect the next rating to be made available sometime around April 28, 2026.
Is the Analyst Rating Crescent Capital BDC (CCAP) correct?
While ratings are subjective and will change, the latest Crescent Capital BDC (CCAP) rating was a maintained with a price target of $18.00 to $16.00. The current price Crescent Capital BDC (CCAP) is trading at is $16.01, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
